Gan & Lee Pharmaceuticals.
603087
Clasificación en acciones
#3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Precio por acción
$10.03
Capitalización bursátil
$5.99B
Cambio (1 día)
-3.71%
Cambio (1 año)
2.30%
País
CN
Comercio Gan & Lee Pharmaceuticals. (603087)
Categoría
Healthcare
Ratio P/S de Gan & Lee Pharmaceuticals. (603087)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Gan & Lee Pharmaceuticals., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Gan & Lee Pharmaceuticals. desde 2013 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2025 | 9.98 | 16.64% |
| 2024 | 8.56 | -25.20% |
| 2023 | 11.44 | 7.09% |
| 2022 | 10.68 | -2.29% |
| 2021 | 10.94 | -50.49% |
| 2020 | 22.08 | 74.82% |
| 2019 | 12.63 | -8.28% |
| 2018 | 13.77 | -0.87% |
| 2017 | 13.89 | -25.30% |
| 2016 | 18.60 | -31.05% |
| 2015 | 26.97 | -23.67% |
| 2014 | 35.34 | -20.02% |
| 2013 | 44.18 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 13.45 | - |
US
|
|
| 2.32 | - |
FR
|
|
| - | - |
JP
|
|
| 2.47 | - |
US
|
|
| - | - |
CH
|
